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Novelty and impact of the paper:  
1. This paper describes that overexpression of BiP is a major factor 
for resistance of cancer cells to a promising gene-therapeutic 
adenenovirus vector carrying REIC/Dkk-3 (Ad-REIC). 
2. Down-regulation of Bip by siRNA sensitizes resistant cancer 
cells to Ad-REIC.  
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 (Summary) 
We have recently shown that an adenovirus carrying REIC/Dkk-3 
(Ad-REIC) exhibits a potent tumor-specific cell-killing function 
for various human cancers. It has also become evident that some 
human cancers are resistant to Ad-REIC-induced apoptosis. The aim 
of the present study was to determine the molecular mechanisms of 
resistance to Ad-REIC. First, we isolated resistant clones from 
a human prostate cancer cell line, PC3, after repeated exposure 
to Ad-REIC. Infection efficiency of the adenovirus vector and 
expression level of REIC/Dkk-3 in the resistant clones were similar 
to those in the parental PC3 cells. By screening for alteration 
in levels and functional status of proteins involved in 
Ad-REIC-induced apoptosis, we found that BiP/GRP78, an ER-residing 
chaperone protein, was expressed at higher levels consistently 
among resistant cells. Expression levels of BiP and rates of 
apoptosis induced by Ad-REIC were inversely correlated. 
Down-regulation of BiP with siRNA sensitized the resistant cells 
to Ad-REIC in vivo as well as in culture. These results indicate 
that BiP is a major determinant of resistance to Ad-REIC-induced 
apoptosis. Thus BiP is useful for diagnosis of inherent and acquired 
resistance of cancers and also as a target molecule to overcome 
resistance to the gene therapeutic Ad-REIC. 
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 (Introduction) 
 REIC/Dkk-3 is a tumor suppressor gene that was first 
identified as a gene that is down-regulated in association with 
immortalization of normal human fibroblasts1. Subsequently, we 
found that overexpression of REIC/Dkk-3 using an adenovirus vector 
(Ad-REIC) has a dramatic therapeutic effect on various types of 
human and cancer, including those derived from the prostate, testis, 
pleura, and breast2-5. Infection with Ad-REIC selectively induced 
apoptotic cell death in cancer cells in a cell-autonomous manner, 
whereas normal cells did not undergo apoptosis upon infection with 
Ad-REIC. Furthermore, intratumoral injection of Ad-REIC was shown 
to inhibit metastasis of mouse prostate cancer in an orthotopic 
model6. These selective multi-targeting anti-cancer functions of 
Ad-REIC show great promise for clinical application, which will 
be shortly initiated. 
One of the major challenges in cancer therapy is overcoming 
inherent and acquired resistance of cancer cells. Re-growth of such 
resistant cell populations annuls initially effective therapeutic 
measures and often leads to fatal outcomes. Cancer gene therapy 
may restore apoptosis in cancer cells that are resistant to 
conventional chemotherapeutic agents and/or radiation7, but gene 
therapeutic modalities, including those using p53 and mda-7/IL-24, 
cannot be free from such a challenge8,9. Pataer et al. 10 isolated 
Ad-mda7/IL-24-resistant lung cancer cell lines and showed that the 
resistance was overcome by an inhibitor for HSP90. Clarification 
of molecular mechanisms underlying resistance to a therapeutic 
measure would contribute not only to overcoming the acquired 
resistance of cancer cells but also to diagnosis of inherently 
resistant cancer cases to avoid application of ineffective 
therapeutic modalities.  
Although REIC/Dkk-3 is a secretory protein and assumed to 
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 exert its physiological function through a yet unidentified cell 
surface receptor, the induction of apoptosis in cancer cells by 
Ad-REIC is mainly due to ER stress induced by overproduction of 
REIC/Dkk-3 in the cells2,3. Activation of c-Jun N-terminal kinase 
(JNK) triggered by ER stress is a critical event for apoptosis 
induced by Ad-REIC2,3. In the present study, we isolated resistant 
clones from a human prostate cancer cell line, PC3, that is sensitive 
to Ad-REIC and found that overexpression of BiP/GRP78, an 
ER-residing chaperone protein, is a major determinant of the 
acquired and inherent resistance to Ad-REIC. Down-regulation of 
BiP using siRNA restored sensitivity of tumors formed by 
transplantation of a resistant clone to therapeutic application 
of Ad-REIC in vivo.  
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 Materials and methods 
Cells culture 
 The human prostate cancer cell lines PC3 and LNCaP were 
cultivated in HAM’S F-12 K medium and RPMI 1640 (Nissui, Tokyo, 
Japan), respectively, with a supplement of 10% FBS.  OUMS-24 cells 
(kindly provided by Dr. Masayoshi Namba) are normal human 
fibroblasts cultured in Dulbecco’s modified MEM (Nissui, Tokyo, 
Japan) supplemented with 10% FBS. Human bladder cancer cell lines 
T24 and J82 were cultivated in McCoy’s 5A medium and MEM, 
respectively, with 10% FBS. For isolation of clones resistant to 
Ad-REIC, PC3 cells were subjected to 3 cycles of massive killing 
by Ad-REIC and recovery over 3 months and then cloned by the limited 
dilution method. Apoptotic cells were identified as those with 
shrunken and fragmented nuclei stained with Hoechst33342 72 h after 
infection with Ad-REIC.  
 
Western blot analysis  
 Western blot analysis was performed under conventional 
conditions using the following antibodies: Rabbit anti-human 
REIC/Dkk-3 antibody raised in our laboratory; rabbit anti-human 
GRP78 (BiP), rabbit anti-human GADD153 (CHOP), mouse anti-human 
mitochondrial HSP70 (GRP75), and rabbit anti-human ATF6 
(N-terminus) antibodies (Abcam, Cambridge, MA); mouse anti-human 
HSP70, mouse anti-human HSP90 and mouse 
anti-phospho-serine/threonin (clone 22a) antibodies (BD 
Biosciences, San Jose, CA); mouse anti-human HSC70, mouse 
anti-human HSP27, goat anti-human GRP78, and rabbit anti-GRP94 
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA); mouse 
anti-β-galactosidase antibody (Calbiochem); rabbit anti-human 
SAPK/JNK, mouse anti-human phospho-SAPK/JNK (Thr183/Tyr185), 
rabbit anti-human p38, rabbit anti-human phospho-p38 
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 (Thr180/Tyr182), rabbit anti-human ASK1, rabbit anti-human 
phospho-ASK1 (Thr845) and rabbit anti-human IRE1α antibodies (Cell 
Signaling Technology, Beverly, MA); rabbit anti-human 
phospho-IRE1α (Ser724) antibody (ABR, Golden, CO); mouse anti-human 
Bcl-2, mouse anti-human Bcl-xL, mouse anti-human Bax and mouse 
anti-human Bad antibodies (BD Biosciences); rabbit anti-human 
calreticulin antibody (Novus Biologicals, Littleton, CO); rabbit 
anti-human DNAJA2 antibody (Proteintech Group, Chicago, IL);   and 
mouse anti-human β-actin and mouse anti-human tubulin antibodies 
(Sigma, St Louis, MO). 
 
Isolation of ERSE-binding proteins in vitro 
 A biotinylated 39-bp DNA fragment containing ER stress 
response element (ERSE) of the human BiP promoter was prepared using 
a forward primer 
(5’-biotin-agggccttcaccaatcggcggcctccacgacggggctgg-3’) and a 
reverse primer 
(3’-ccagccccgtcgtggaggccgccgattggtgaaggccct-biotin-5’). 
Proteins that bind to the biotinylated DNA fragment were identified 
in nuclear extracts under conditions described previously11.  
 
Transfection of siRNA and decoy oligonucleotides in culture 
 Small interfering RNAs (siRNAs) against human BiP (StealthTM; 
siRNAs duplex oligonucleotide for BiP; CGAGUGACAGCUGAAGACAAGGGUA) 
and a control siRNA (Silencer negative control 2 siRNA) were 
purchased from Invitrogen and Ambion (Austin, Texas), respectively. 
Transfection of siRNAs (final concentration of 0.2 μM) was performed 
using FuGENE-HD (Roche). Decoy oligonucleotides for transcription 
factors were prepared by annealing complementary oligonucleotides 
having the following sequences: 5'-ccaatcggcggcctccacg-3' for 
ATF-6, 5'-atgaatcag-3' for AP-1, 5'-ttcctggaa-3' for STAT, 
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 5'-cataactggc-3' and 5'-CCCAACTGGC-3' for c-Myb, and 
5'-agcagccaatga-3' and 5'-ctgggccaatga-3' for C/EBP. Transfection 
of the oligonucleotides (final concentration of 10 μM) was performed 
using lipofectamineTM 2000 (Invitrogen) with NupherinTM reagent 
(Biomol). 
 
Tumor growth assay in vivo 
 PC3-derived Cl-1 cells (5x106 in 100 μl PBS) mixed with 100 
μl Matrigel (BD Biosciences) were subcutaneously injected into the 
right flank of adult male BALB/c nu/nu mice (SLC, Hamamatsu, Japan). 
One week after transplantation (~5 mm in diameter), 4 μg of siRNAs 
in 200 μl of TransIT-QR Hydrodynamic Delivery Solution (Mirus, 
Madison, WI) was injected intratumorally into 4 different sites. 
Twenty-four hours later, Ad-REIC or Ad-LacZ (2x108 pfu) in 200 μl 
of a buffer was injected intratumorally. Tumor volume was calculated 
using an empirical formula, V = 1/2 x [(shortest diameter)2 x 
(longest diameter)]. PC-3M-luc-C6 Bioware cells (PC3-Luc; Caliper 
Life Sciences, Hopkinton, MA) transplanted under the same 
conditions as those for PC3 cells were used for monitoring the effect 
of siRNA in vivo using IVIS 2000 (Xenogen, Alameda, CA). The 
experiments were performed according to the ethical code for 
experimental animal handling of our university. 
 
Statistical analysis 
 Results were expressed as means +/- SD unless otherwise 
indicated.  Statistical analysis was performed by Mann-Whitney's 
U-test.  P values equal to or less than 0.05 were considered 
statistically significant. 
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 Results 
Isolation and characterization of resistant clones from PC3 cells 
to Ad-REIC 
 To isolate resistant variants, PC3 cells were exposed to 
Ad-REIC at 20 MOI, which induced massive cell death. A small number 
of surviving cells were further propagated and re-infected with 
Ad-REIC under the same conditions. After three rounds of infection 
with Ad-REIC and recovery, the cells were seeded into a 96-well 
plate for single cell cloning. The resulting clones showed varying 
sensitivity to Ad-REIC (Fig. 1a), i.e., resistant (Cl-1~Cl-5), 
intermediate (Cl-6~Cl-9), and sensitive (Cl-10, Cl-11) clones were 
obtained. Infection efficiency of Ad-LacZ among the clones was not 
remarkably altered (Fig. 1b), excluding the possibility that the 
resistance to Ad-REIC was due to failure in infection. Expression 
level of REIC/Dkk-3 protein in Cl-1 cells was similar to that in 
PC3 cells after infection with Ad-REIC (Fig. 1c). 
 Since our previous studies showed that up-regulation of 
HSP70 and Bcl-2 may be responsible for conferring upon cells 
resistance to Ad-REIC12,13, we first examined expression levels of 
heat shock proteins (HSPs)/chaperones and Bcl-2-related proteins 
of a representative resistant clone, Cl-1 (Fig. 1c). No significant 
change in expression of HSP90, HSP70, and HSC70 was observed in 
Cl-1 cells compared with that in PC3 cells. On the other hand, Bcl-2 
and Bcl-xL were down- and up-regulated, respectively, in Cl-1 cells. 
Overall effect of the alteration, however, is probably not very 
significant, because both Bcl-2 and Bcl-xL have anti-apoptotic 
function and thus are mostly complementary14. We particularly noted 
that BiP, an ER-specific chaperone protein, was up-regulated in 
Cl-1 cells, since Ad-REIC induces apoptosis by triggering ER stress. 
BiP, but not HSPs, was up-regulated in all of the resistant clones 
isolated (Fig. 1d). The lower major band of BiP appeared genuine 
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 since a single band corresponding to its size was detected with 
a different antibody against BiP (Fig. 4a).  
 
Signal transduction leading to overexpression of BiP in Cl-1 cells 
 Various potential cis-acting regulatory elements were 
revealed by a computer search to be present in the promoter of BiP 
(Fig. 2a, upper panel). Among the corresponding decoy 
oligonucleotides, only that for ERSE suppressed expression of BiP 
upon transfection to Cl-1 cells (Fig. 2a, lower panel). The ERSE 
is known to be activated by binding with ATF6, a sensor protein 
truncated and phosphorylated by p38 under the ER stress 
conditions15,16. Truncated ATF6 was constitutively detected in Cl-1 
cells, while the truncated form was observed in PC3 cells only upon 
infection with Ad-REIC, which evoked ER stress (Fig. 2b). In vitro 
fishing of transacting factors using the biotinylated ERSE resulted 
in identification of the activated ATF6 (Fig. 2c). Binding of 
constitutively active ATF6 together with YY1 in the Cl-1 cell 
extract to the ERSE was observed (Data not shown). p38 inhibitors 
abrogated the binding of ATF6 to the ERSE (Fig. 2d) and 
overexpression of BiP (Fig. 2e). p38 and its upstream kinase ASK1, 
but not IRE1α, were constitutively active in Cl-1 cells as indicated 
by phosphorylation (Fig. 2f). Inactive IRE1α in Cl-1 cells was 
confirmed by the lack of splicing of XBP1 mRNA (Fig. 2g). In Cl-1 
cells, activation of IRE1α and JNK was not observed even upon 
exposure to Ad-REIC (Fig. 2f). These results indicate that Cl-1 
cells were refractory to the induction of ER stress by Ad-REIC and 
that overexpression of BiP in Cl-1 cells was due to constitutive 
cleavage of ATF6 and activation of ASK1 for a yet unidentified 
reason. 
 
Causative link between overexpression of BiP and resistance to 
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 Ad-REIC 
 Next we investigated whether overexpression of BiP in the 
resistant clones is causatively linked to their resistance to 
Ad-REIC. Expression level of BiP was high in highly resistant clones 
but not in intermediate and sensitive clones (Fig. 3a). A reverse 
correlation (γ=-0.75) was found between the rate of cell apoptosis 
induced by Ad-REIC and BiP protein level among different clones. 
The correlation between Ad-REIC-induced apoptosis and protein level 
of either HSP70 (γ=0.003) or Bcl-2 (γ=-0.32) was not remarkable. 
A similar reverse correlation was observed among PC3 cells exposed 
for different times (1~4) to Ad-REIC and some other cancer cell 
lines (γ=-0.93; Fig. 3b). It should be noted that repeated exposure 
of PC3 cells to Ad-REIC progressively promoted expression of BiP 
and resistance to Ad-REIC.  
 Transfection of BiP siRNA efficiently down-regulated BiP 
expression in Cl-1 cells in culture (Fig. 4a). The effect of BiP 
siRNA was specific since levels of chaperone proteins such as HSP70, 
HSC70, HSP90, HSP27, GRP94, GRP75, calreticulin, and DNAJA2 were 
not altered by the siRNA.  This treatment sensitized Cl-1 cells to 
induction of apoptosis by Ad-REIC, i.e., from 4% in the cells 
transfected with control siRNA to 38% in those with BiP siRNA (Fig. 
4b). Similar sensitization of another resistant clone, Cl-3, and 
resistant bladder cancer cell lines, T24 and J82, was observed (Fig. 
4c). It is notable that down-regulation of BiP in normal human 
fibroblasts (OUMS-24) did not result in sensitization, though the 
cells expressed BiP to a level similar to the levels in Cl-1 and 
T24 cells (Fig. 4b). Normal cells probably have additional 
protective mechanisms against Ad-REIC. Down regulation of BiP in 
Cl-1 cells resulted in alteration in the signal transduction from 
ER stress to activation of JNK, a critical event leading to 
apoptosis2. On infection of BiP siRNA-treated Cl-1 cells with 
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 Ad-REIC resulted in phosphorylation of IRE1α and activation of the 
down stream JNK (Fig. 4d). Similar response was observed in PC3 
cells but not in Cl-1 cells (Fig. 2d). These results indicate that 
expression level of BiP is the critical determinant for resistance 
of cancer cells to Ad-REIC. 
 
Sensitization of Cl-1 cells to therapeutic Ad-REIC by BiP siRNA 
in vivo 
 Transfection of siRNA and successful down-regulation of the 
target gene in vivo were verified using luciferase siRNA in tumors 
formed by transplantation of PC3-Luc cells (Fig. 5a). Transfection 
of BiP siRNA under similar conditions resulted in marked 
down-regulation of BiP in tumors formed by Cl-1 cells (Fig. 5b). 
The down-regulation of BiP significantly suppressed the growth of 
tumors formed by transplantation of Cl-1 cells in vivo (Fig. 5c). 
Histological examination of the tumors revealed heterogeneous 
appearance of tissues, but in general the progressively growing 
tumors were mainly occupied by viable tumor cells, while those 
treated with BiP siRNA and Ad-REIC were composed of many 
degenerative cells (data not shown). 
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 Discussion 
 In the present study, we showed that: 1) BiP was overexpressed 
in resistant clones derived from PC3 cells and intrinsically 
resistant cancer cells to Ad-REIC (Fig. 1), 2) rates of apoptosis 
induced by Ad-REIC and expression levels of BiP among different 
cell types were inversely correlated (Fig. 3), and 3) 
down-regulation of BiP resulted in sensitization of the resistant 
cells to Ad-REIC (Figs. 4 and 5). These results indicate that BiP 
is a critical determinant of sensitivity/resistance to Ad-REIC. 
This is conceivable since BiP is an ER-residing chaperone protein 
negatively regulating ER stress and Ad-REIC exerts its 
apoptosis-inducing activity through ER stress2,3,12. Application of 
purified REIC/Dkk-3 protein failed to induce apoptosis in cancer 
cells. Ad-mda-7/IL-24, a promising gene therapeutic agent, was also 
shown to exhibit its effect partly through ER stress10,17. Pataer et 
al.10 isolated clones resistant to overexpression of mda-7/IL-24 
from a lung cancer cell line and showed that the clones were 
partially sensitized by an HSP90 inhibitor, 17AAG. However, 
functional status of BiP was not described.  
BiP has been attracting much interest for its role in 
resistance of cancer cells to a broad variety of therapeutic 
measures, many of which are not directly linked to ER stress18. 
Although BiP is primarily located in the ER, it has also been shown 
to interact with cytosolic executors of apoptosis, such as caspase 
7 and BIK19,20, and even to be present even on the cell surface21. The 
particularly good inverse correlation between rates of apoptosis 
induced by Ad-REIC and expression levels of BiP (Fig. 3) was probably 
due to the fact that Ad-REIC induces apoptosis via ER stress. This 
indicates that determination of BiP level in a given cancer is a 
valid test for the effectiveness of gene therapy using Ad-REIC, 
although BiP is considered to play a critical role in a broad variety 
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 of cancer therapies18.  
Down-regulation of BiP sensitized resistant cancer cells not 
only to Ad-REIC as shown in the present study but also to many 
chemotherapeutic agents18. Transfection with siRNA in vivo was 
effective in reducing target proteins in the present experimental 
settings (Fig. 5). However, it is unlikely that a similar method 
can be applied to human cancer, and safer and more effective methods 
for gene delivery are needed. Substances to inhibit BiP have been 
intensively screened and some candidate molecules have been 
reported22,23. It should be noted that normal human fibroblasts, 
OUMS-24, were not sensitized to Ad-REIC by down-regulation of BiP 
(Fig. 4B). Combination of a BiP inhibitor with Ad-REIC should 
therefore lead to a potent and specific therapeutic approach against 
inherent and acquired resistant cancers in the near future. 
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 Figure Legends 
 
FIGURE 1 - Isolation of PC3 cell clones resistant to Ad-REIC and 
overexpression of BiP in the resistant clones.  (a) Rates of 
apoptosis induced by Ad-REIC (20 MOI) of PC3 cells and PC3-derived 
clones (Cl-1~Cl-11) that were obtained after exposure to Ad-REIC 
3 times. (b) Infection efficiency of Ad-LacZ to PC3 cells and 
PC3-derived clones determined by staining with X-gal after 
infection with Ad-LacZ at 20 MOI.  (c) Western blot analysis for 
proteins belonging to the family of heat shock/chaperone proteins 
and Bcl family proteins. Cell extracts were prepared 24 h after 
infection with Ad-LacZ or Ad-REIC at 20 MOI. Tubulin was used as 
a control. (d) Western blot analysis for heat shock/chaperone 
proteins of different cell lines and PC3-derived resistant clones 
(Cl-1~Cl-5). LNCaP and DU145 cells (prostate cancer) and HeLa cells 
(cervical cancer) are sensitive to Ad-REIC (data not shown).  
 
FIGURE 2 - Signal transduction leading to overexpression of BiP in 
a resistant clone, Cl-1. (a) Identification of a critical cis-acting 
regulatory element(s) in the BiP promoter of Cl-1 cells. Upper 
panel: Candidate cis-elements in the BiP promoter identified by 
MOTIF Search provided by Kyoto University Bioinformatics Center. 
Lower panel: Down-regulation of BiP by transfection of synthetic 
decoy oligonucleotides corresponding the candidate cis-elements. 
ERSE, ER stress-responsive element. (b) Western blot analysis for 
ATF6 of PC3 and Cl-1 cells 24 h after infection with Ad-LacZ or 
Ad-REIC at 20 MOI. (c) Identification of ATF6 as a protein binding 
to ERSE in vitro (see Materials and Methods). P-ATF6, phosphorylated 
ATF6, was detected using a mouse anti-phospho-serine/threonine 
antibody.  (d) In vitro fishing for ATF6 using the ERSE in cells 
exposed to inhibitors for p38 (SB203580 1 μM), JNK (SP600125 100 
19 
 nM), and Akt (Akt I 10 μM) for 24 h. (e) Inhibition of BiP expression 
in Cl-1 cells by p38 inhibitors. The cells were exposed to inhibitors 
for p38 (SB203580, 1 μM; SC68376 10 μM) and for JNK (SP600125 100 
nM) for 24 h. (f) Splicing of XBP1 mRNA examined by RT-PCR. Closed 
arrowhead, unspliced; open arrowhead, spliced. (g) Western blot 
analysis for proteins potentially involved in the signal 
transduction triggered by ER stress. P-, phosphorylated. Cell 
extracts in (c) and (f) were the same as those used for the experiment 
shown in (b).  
 
FIGURE 3 - Inverse correlation between expression level of BiP and 
sensitivity to killing effect of Ad-REIC. (a) Upper panel: Western 
blot analysis for BiP, HSP70 and Bcl-2 in PC3 cells and PC3-derived 
clones with varying resistance to Ad-REIC. Lower panel: Correlation 
between rates of apoptosis induced by Ad-REIC and expression levels 
of BiP among different clones. γ, correlation coefficient. (b) 
Analysis similar to that described in (a) in PC3 cells and 
PC3-derived populations that survived different cycles of Ad-REIC 
infection and recovery (C0~C4; 0 to 4 times).  LNCaP is a sensitive 
prostate cancer cell line, and T24 and J82 are resistant bladder 
cancer cell lines.  
 
FIGURE 4 - Sensitization of cancer cells to Ad-REIC by down regulation 
of BiP using siRNA. (a) down-regulation of BiP (detected with an 
antibody from Santa Cruz Biotechnology) by siRNA in Cl-1 cells shown 
by Western blot analysis. Cells were analyzed 48 h after 
transfection with siRNAs (0.2 μM). (b) sensitization of Cl-1 cells 
but not OUMS-24 cells to Ad-REIC by down-regulation of BiP using 
siRNA.  (c) sensitization of different cell types to Ad-REIC (20 
MOI) by transfection of BiP siRNA (0.2 μM) 24 h prior to the Ad-REIC 
challenge. (d) alteration in levels of proteins potentially 
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involved in the signal transduction triggered by ER stress in Cl-1 
cells. P-, phosphorylated. 
 
FIGURE 5 - Down-regulation of BiP resulted in sensitization of Cl-1 
cells to Ad-REIC in vivo. (a) Down-regulation of luciferase activity 
of PC3-Luc cells by transfecting siRNA for luciferase in vivo. Open 
and shadowed columns are before and 3 days after application of 
siRNA normalized to the values of Day 0. Vertical bars, standard 
error among 5 mice.  *, p=0.05. (b) Down-regulation of BiP in tumors 
formed by Cl-1 cells determined 3 days after transfection with the 
siRNA.  Three tumors were examined. (c) Sensitization of Cl-1 cells 
to Ad-REIC by transfecting BiP siRNA in vivo. Vertical bars, 
standard error among 5 mice. *, p<0.05. 
 
 





